GEN EdgeVol. 1, No. 1 Metabolic DisordersDicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi PartnershipAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:21 Nov 2019https://doi.org/10.1089/genedge.1.1.35AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 1Issue 1Jan 2019 Information© 2019 by GEN PublishingTo cite this article:Alex Philippidis.Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership.GEN Edge.Jan 2019.172-174.http://doi.org/10.1089/genedge.1.1.35Published in Volume: 1 Issue 1: November 21, 2019PDF download